Trial
NCT03919162
A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vivoryon Therapeutics N.V.
Collaborators
Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA)
Condition
Alzheimer Disease
Intervention
PQ912
Why stopped
It has been made the strategic decision to terminate the study. This decision to terminate the study early is not being made for safety reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-12